Medacta Group S.A.
[WKN: A2PFTD | ISIN: CH0468525222]
Aktienkurse
123,700€ -0,32%
Echtzeit-Aktienkurs Medacta Group S.A.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Corporate News: Medacta Group SA

Medacta is pleased to announce the first European Peri-Acetabular Osteotomy procedures using the MyPAO Platform, a unique solution for acetabular…

Corporate News: Medacta Group SA

Medacta showcases NextAR Spine MIS LT procedure at Spine Week, efficiently complementing operative workflow for spine surgery...…

Corporate News: Medacta Group SA

Medactas P-Family Hip System offering is now more complete with the introduction of the new SMS Collared Stem...…

Corporate News: Medacta Group SA

New clinical study demonstrates Medactas MySpine accuracy in screw replacement during spine revision surgery...…

Corporate News: Medacta Group SA

Medacta to Showcase MyKA Kinematic Alignment Platform and NextAR Augmented Reality Surgical Platform at AAOS 2023...…

Medacta mit kräftigem Umsatzplus

Medtech - Das Tessiner Orthopädieunternehmen Medacta hat im Jahr 2022 den Umsatz erneut kräftig gesteigert. Einen Ausblick auf das Ergebnis…

Ad-hoc News: Medacta Group SA

Medacta Group SA: 2022 Full Year Unaudited Top-Line Figures release / Today’s call at 4:00pm CET...…

Corporate News: Medacta Group SA

Medacta Group SA: First NextAR surgeries in Japan with the award-winning NextAR Augmented Reality Surgical Platform...…

Corporate News: Medacta Group SA

Medacta Group SA: Medacta Expands its Hip Offerings with New Cobalt-Free SensiTiN™ Double Mobility Converter...…

Corporate News: Medacta Group SA

Medacta NextAR Spine wins the 2022 Spine Technology Award from Orthopedics This Week during North American Spine Society Annual Meeting...…